Zurcher Kantonalbank (Zurich Cantonalbank) - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$31,717
-34.4%
7,3420.0%0.00%
Q2 2023$48,384
-2.9%
7,3420.0%0.00%
Q1 2023$49,852
-8.1%
7,3420.0%0.00%
Q4 2022$54,257
-25.7%
7,3420.0%0.00%
Q3 2022$73,000
-8.8%
7,3420.0%0.00%
Q2 2022$80,000
-3.6%
7,3420.0%0.00%
Q1 2022$83,000
-27.8%
7,3420.0%0.00%
-100.0%
Q4 2021$115,000
+17.3%
7,342
+28.0%
0.00%0.0%
Q3 2021$98,000
-22.2%
5,736
-40.1%
0.00%0.0%
Q4 2020$126,000
+37.0%
9,5750.0%0.00%0.0%
Q3 2020$92,000
-16.4%
9,5750.0%0.00%0.0%
Q2 2020$110,000
+175.0%
9,575
+147.0%
0.00%
Q1 2020$40,000
-37.5%
3,8760.0%0.00%
Q4 2019$64,000
+25.5%
3,8760.0%0.00%
Q3 2019$51,000
-7.3%
3,8760.0%0.00%
Q2 2019$55,000
-22.5%
3,8760.0%0.00%
-100.0%
Q1 2019$71,000
-29.7%
3,876
+0.5%
0.00%0.0%
Q4 2018$101,000
+14.8%
3,8550.0%0.00%0.0%
Q3 2018$88,000
+33.3%
3,855
+11.2%
0.00%0.0%
Q2 2018$66,000
+153.8%
3,467
+127.0%
0.00%
Q1 2018$26,000
+13.0%
1,5270.0%0.00%
Q4 2017$23,000
-14.8%
1,5270.0%0.00%
Q3 2017$27,000
+8.0%
1,5270.0%0.00%
Q2 2017$25,000
+19.0%
1,5270.0%0.00%
Q1 2017$21,000
-12.5%
1,5270.0%0.00%
Q4 2016$24,000
-4.0%
1,5270.0%0.00%
Q3 2016$25,000
+108.3%
1,527
+47.7%
0.00%
Q2 2016$12,000
+33.3%
1,0340.0%0.00%
Q1 2016$9,000
-10.0%
1,0340.0%0.00%
Q4 2015$10,000
-16.7%
1,0340.0%0.00%
Q3 2015$12,0001,0340.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Palo Alto Investors LP 2,491,200$27,154,0002.37%
Profit Investment Management, LLC 281,890$3,071,0002.26%
Sio Capital Management, LLC 488,965$5,330,0002.00%
Zebra Capital Management LLC 14,766$161,0000.47%
Prairiewood Capital, LLC 50,165$547,0000.43%
TANG CAPITAL MANAGEMENT LLC 256,696$2,798,0000.42%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$1,700,0000.29%
GLOBEFLEX CAPITAL L P 100,843$1,099,0000.27%
Epoch Investment Partners, Inc. 2,757,646$30,059,0000.18%
EMC Capital Management 16,185$176,0000.15%
View complete list of VANDA PHARMACEUTICALS INC shareholders